General Information of Drug (ID: DMMHQYB)

Drug Name
phosphatidyl (3,5) inositol biphosphate Drug Info
Synonyms phosphatidylinositol 3,5-bisphosphate; PI(3,5)P2
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
643961
ChEBI ID
CHEBI:82954
CAS Number
CAS 214282-36-7
TTD Drug ID
DMMHQYB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Preclinical Drug(s)
Drug(s) Targeting Mucolipin-1 (TRPML1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MK6-83 DMI3E0Y Discovery agent N.A. Preclinical [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mucolipin-1 (TRPML1) TT9XBVO MCLN1_HUMAN Activator [2]
Two pore calcium channel protein 1 (TPC1) TTODQE2 TPC1_HUMAN Activator [3]
Two pore calcium channel protein 2 (TPC2) TTZWC8B TPC2_HUMAN Activator [4]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2794).
2 PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun. 2010 Jul 13;1:38.
3 The voltage-gated sodium channel TPC1 confers endolysosomal excitability. Nat Chem Biol. 2014 Jun;10(6):463-9.
4 TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes. Cell. 2012 Oct 12;151(2):372-83.
5 ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity. Antiviral Res. 2020 Oct;182:104922.